DrugDashboards

Ipratropium Bromide and Albuterol Sulfate

Ipratropium Bromide and Albuterol Sulfate · IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mL · Solution · Respiratory (Inhalation) · Nephron Pharmaceuticals Corporation

NDC 00487-0201-60 · 12 POUCH in 1 CARTON / 5 VIAL, SINGLE-USE in 1 POUCH / 3 mL in 1 VIAL, SINGLE-USE · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.0855 per mL over the past year. One of its named manufacturing plants, Nephron SC, LLC, failed FDA inspectionwithin the last two years — the agency’s most serious outcome. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0855per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.2010per billing unit (2.5 MG/0.5 MG)HCPCS J7620 · Jul 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.05$0.1Nov 2013Sep 2026$0.0855
155 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$18.00
Reported to Texas DSHS · 2025 annual filing · Nephron Pharmaceuticals Corporation

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 2.5 MG/0.5 MG
$0.201
HCPCS J7620 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$1.0M
53,778 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for ipratropium bromide and albuterol sulfate (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA076749
TE code
AN
Approval date
Dec 31, 2007
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedApr 13, 2022
    Mckesson Medical-Surgical Inc. Corporate Office — cGMP deviations: Temperature abuse
  • Class II · TerminatedAug 21, 2015
    Nephron Pharmaceuticals Corp. — Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling process

Manufacturers of Ipratropium Bromide and Albuterol Sulfate (Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsIPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
A-S Medication SolutionsALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Sep 2, 2026
American Health PackagingALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Sep 2, 2026
Aurobindo Pharma LimitedALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Sep 2, 2026
Chartwell RX, LLCIPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
Cipla USA Inc.IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 2.5 mg/3mLAug 26, 2026Sep 2, 2026
Golden State Medical Supply, Inc.ALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Sep 2, 2026
Mylan Pharmaceuticals Inc.IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 2.5 mg/3mLAug 26, 2026Sep 2, 2026
Nephron Pharmaceuticals CorporationIPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
Preferred Pharmaceuticals Inc.IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
Proficient Rx LPIPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
Proficient Rx LPIPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 2.5 mg/3mLAug 26, 2026Sep 2, 2026
Redpharm DrugALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLAug 19, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 3 mg/3mLAug 26, 2026Sep 2, 2026
Ritedose Pharmaceuticals, LLCALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.IPRATROPIUM BROMIDE .5 mg/3mL; ALBUTEROL SULFATE 2.5 mg/3mLAug 26, 2026Sep 2, 2026
Cipla USA Inc.ALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Aug 30, 2026
A-S Medication SolutionsIPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Chartwell RX, LLCIPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Cipla USA Inc.IPRATROPIUM BROMIDE 2.5 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Mylan Pharmaceuticals Inc.IPRATROPIUM BROMIDE 2.5 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Nephron Pharmaceuticals CorporationIPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Preferred Pharmaceuticals Inc.IPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Proficient Rx LPIPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Proficient Rx LPIPRATROPIUM BROMIDE 2.5 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Rising Pharma Holdings, Inc.IPRATROPIUM BROMIDE 3 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
Sun Pharmaceutical Industries, Inc.IPRATROPIUM BROMIDE 2.5 mg/3mL; ALBUTEROL SULFATE .5 mg/3mLJul 22, 2026Aug 19, 2026
A-S Medication SolutionsALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Chartwell RX, LLCALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Mylan Pharmaceuticals Inc.ALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Nephron Pharmaceuticals CorporationALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Preferred Pharmaceuticals Inc.ALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Proficient Rx LPALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Proficient Rx LPALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Rising Pharma Holdings, Inc.ALBUTEROL SULFATE 3 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026
Sun Pharmaceutical Industries, Inc.ALBUTEROL SULFATE 2.5 mg/3mL; IPRATROPIUM BROMIDE .5 mg/3mLJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ipratropium Bromide and Albuterol Sulfate — NDC 00487-0201-60," retrieved September 3, 2026, https://drugdashboards.com/drug/00487020160.

Free to cite with attribution — see how the data is put together.